CIN2, p16INK4a, HPV E4, molecular biomarker, risk stratification
Showing 26 - 50 of >10,000
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
HPV Vaccine on Menstrual Cycle in Women of Reproductive Age
Not yet recruiting
- Menstrual Disorder
- Premature Ovarian Failure
- prophylactic HPV vaccine(bivalent HPV、quadrivalent HPV、9-valent HPV)
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cente
Apr 20, 2023
CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic
Recruiting
- CIN3
- +3 more
- Vvax001 therapeutic cancer vaccine
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Primary Cervical Cancer Screening by Self-sampling HPV Test
Recruiting
- Human Papillomavirus Infection
- +16 more
-
Beijing, Beijing, China
- +5 more
Jan 12, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)
Not yet recruiting
- Early-stage Breast Cancer
- Atezolizumab 1200 mg in 20 ML Injection
- +5 more
-
Heidelberg, Baden-Wuerttemberg, GermanyNational Center for Tumor Diseases
Sep 13, 2022
Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- Cervical Dysplasia
- 9-valent HPV vaccine
- Imiquimod
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 5, 2022
Cervical Dysplasia, Cervical Cancer Trial in New York (NavDx(R))
Recruiting
- Cervical Dysplasia
- Cervical Cancer
- NavDx(R)
-
New York, New YorkLenox Hill Hospital
Oct 31, 2022
Cervical Cancer Trial (HPV genotyping, Visual inspection after application of acetic acid)
Not yet recruiting
- Cervical Cancer
- HPV genotyping
- Visual inspection after application of acetic acid
- (no location specified)
Nov 1, 2022
sST2 and Troponin I-hs in Patients With Acute Chest Pain
Active, not recruiting
- Acute Chest Pain
- Acute Coronary Syndrome
- Multimarker approach in acute coronary syndrome
-
Roma, ItalySilvia Baroni
Feb 21, 2023
PRETEXT Stage 1 Hepatoblastoma, PRETEXT Stage 2 Hepatoblastoma, PRETEXT Stage 3 Hepatoblastoma Trial in Worldwide (drug, other,
Active, not recruiting
- PRETEXT Stage 1 Hepatoblastoma
- +3 more
- Cisplatin
- +9 more
-
Birmingham, Alabama
- +208 more
Jan 25, 2023
Patients With Previously Diagnosed High-Risk Neuroblastoma
Active, not recruiting
- Recurrent Neuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Birmingham, Alabama
- +97 more
Oct 28, 2022
HSIL of Cervix Trial in Heze (NWRD08)
Recruiting
- HSIL of Cervix
- NWRD08
-
Heze, Shandong, ChinaHeze Municipal Hospital
Jun 6, 2023
Cervical Cancer Screening With Human Papillomavirus Testing
Recruiting
- CIN3
- +2 more
- HPV screening
-
Buenos Aires, Argentina
- +11 more
Apr 1, 2022
NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
- (no location specified)
Mar 7, 2023
Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting
- Human Papillomavirus Infection
- +17 more
-
Beijing, Beijing, China
- +2 more
Jan 21, 2022
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Palbociclib
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 25, 2022
Patients With Myocarditis
Not yet recruiting
- Myocarditis
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 17, 2023
Cardiac Biomarkers and Analytical Methods
Active, not recruiting
- Cardiovascular Diseases
- Myocardial Injury
-
Roma, ItalySilvia Baroni
Mar 12, 2023
Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3 Trial (VTD-101 ointment)
Not yet recruiting
- Vulvar Intraepithelial Neoplasia Grade 2
- Vulvar Intraepithelial Neoplasia Grade 3
- VTD-101 ointment
- (no location specified)
Feb 3, 2023
Cervical Intraepithelial Neoplasia Using Self-collected
Enrolling by invitation
- HPV - Anogenital Human Papilloma Virus Infection
- Menstrual Blood Analysis (Menstrual Blood Analysis)
-
Palo Alto, CaliforniaStanford Gynecology Clinic
Dec 1, 2022
Human Papillomavirus (HPV), Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in New York (radiation, other, drug)
Withdrawn
- Human Papillomavirus (HPV)
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- RT 50 Gy
- +6 more
-
New York, New YorkMount Sinai Hospital
Jul 1, 2022
HPV Infection Trial in Vienna (FluBHPVE6E7)
Recruiting
- HPV Infection
- FluBHPVE6E7
-
Vienna, AustriaMedical University of Vienna
Sep 23, 2021
Plasma Circulating HPV DNA Testing to Management of Cervical
Suspended
- Cervix Lesion
- Cervical Cancer
- digital PCR (dPCR) assay
-
Chapel Hill, North CarolinaOlivia Roberts
Oct 21, 2021
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,
Recruiting
- Ganglioneuroblastoma
- +3 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +219 more
Aug 17, 2022